Back to search

Boston University

Zinc protoporphyrin and iron deficiency in children: prevalence, trends, and response to therapy in an urban primary care center

Abstract

dc:description.abstract

Background: The American Academy of Pediatrics recommends routine treatment of iron deficiency (ID) due to its potential adverse neurodevelopmental consequences. Optimal testing to diagnose ID without anemia remains unclear. Zinc protoporphyrin (ZPP) has been found to be a valid and inexpensive indicator of ID but is not routinely collected in clinical practices. Evidence suggests that low-income children are at high risk for ID. Objective: To 1) describe the prevalence of ID as measured by ZPP in a low-income population, 2) describe the natural history of ZPP over time, and 3) examine the relationship between iron prescription and ZPP and implications for screening. Design/Methods: This was a retrospective longitudinal study of data from the electronic medical records at Boston Medical Center from 1/1/02 to 12/31/10. Children with a baseline CBC drawn between age 8-18 months and routine screening results for CBC, lead, and ZPP at baseline and follow-up within 2 years were included. Children with sickle cell disease or elevated lead value (≥10 mcg/dL) were excluded. Multivariate logistic regression was used to determine the association between iron prescription and ZPP at follow-up. Results: Ofthe 2612 eligible children, 79% were publicly insured and 65% were Black. Overall, 48% of these children had an abnormal ZPP level (≥35 mcg/dL). Among those with an abnormal ZPP at baseline (n=1254), 18% were prescribed iron. Improvement in ZPP was found in both groups. Iron prescription was significantly associated with improvement in ZPP (OR 1.5, 95% CI 1.1-2.0) and greater mean change in ZPP (p=0.01). In the multivariate analysis, the effect of iron prescription on improvement in ZPP was modified by hemoglobin level. Among those with abnormal ZPP and anemia at baseline (n=189), interim iron prescription was significantly associated with ZPP improvement at follow-up (aOR 2.4, 95% CI 1.1-5.0). Among children without anemia, iron was rarely prescribed and no significant association with ZPP improvement was found. Conclusions: ID, as measured by elevated ZPP , was common in this low-income population, the majority of whom showed improvement at follow-up. Iron prescription was significantly associated with ZPP improvement. Our data suggest that ZPP may be an appropriate method for screening for ID and monitoring response to therapy.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Health Services Research
Grantor dc:publisher
Boston University
Year dc:date.issued
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Magge, Hema Natesh

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Dc Identifier Other
(ALMA)contemp

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Magge, Hema Natesh. Zinc protoporphyrin and iron deficiency in children: prevalence, trends, and response to therapy in an urban primary care center. masters thesis, Boston University, 2012. https://hdl.handle.net/2144/12497